Pellegrini-Stieda Lesion: When Medial Knee Pain Hides in Plain Sight

A Pellegrini-Stieda (PS) lesion is a specific post-traumatic complication of a medial collateral ligament (MCL) injury — not the injury itself. When the MCL is torn, particularly at its proximal attachment to the medial femoral condyle, local bleeding and inflammation can trigger the body to deposit calcium or form heterotopic bone within the healing ligament tissue. This calcification is the PS lesion.

A standard MCL sprain involves tearing or stretching of the ligament fibers under valgus stress. The MCL heals through collagen remodeling over 6–12 weeks in most cases, and the patient recovers. In a subset of patients — particularly young athletic males — the healing process is complicated by this secondary calcification, which forms 2–6 weeks after the original injury and produces a new wave of medial knee pain and stiffness.

The key clinical distinction is the temporal pattern: an MCL sprain improves progressively after injury. Pellegrini-Stieda syndrome is characterized by initial improvement followed by a secondary worsening as the calcification develops and becomes inflamed. This delayed recurrence is diagnostically important and should prompt imaging even if initial X-rays were unremarkable.

It is also worth noting that not every MCL injury results in a PS lesion, and not every PS lesion causes symptoms. The lesion can be entirely asymptomatic — found incidentally on X-rays taken for another reason — while the syndrome refers specifically to cases where the calcification is symptomatic.

On plain radiograph, the classic Pellegrini-Stieda sign is a curvilinear or linear opacity in the soft tissue adjacent to the medial femoral condyle, running roughly parallel to the long axis of the femoral shaft. The calcification is located at or just distal to the medial epicondyle, where the proximal MCL attaches.

In the early phase (2–4 weeks post-injury), the calcification is faint and may appear as a subtle haziness adjacent to the condyle. In the mature phase, it becomes a well-defined, denser linear or lobulated calcific mass.

Distinguishing it from other medial knee calcifications:

• Stieda fracture: An acute avulsion fragment from the MCL insertion. Unlike PS lesion, it has sharp angular margins and appears immediately after injury. PS lesion is seen weeks to months later with softer, rounded margins.
• Osteochondroma: A bony exostosis with medullary continuity to the underlying femoral cortex. PS lesion is separate from the cortex, positioned within the periligamentous soft tissue.
• Myositis ossificans: The radiographic hallmark is a peripheral dense rim with a radiolucent center — the opposite pattern of PS lesion, which is uniformly dense. Myositis ossificans also occurs in muscle, not in a ligament.
• Loose intra-articular body: These are within the joint space and typically mobile on serial films. PS lesion is extra-articular and fixed in location.

When in doubt, MRI resolves the ambiguity — the signal characteristics of PS lesion (uniformly low signal on all sequences), combined with MCL thickening and periligamentous edema, are distinguishing features that do not overlap with the other entities listed.

Yes — in most cases — but with phase-specific considerations that are important for patient safety and outcomes. Manipulation is not categorically contraindicated by a PS lesion, but certain technique choices require modification depending on the lesion's activity and the integrity of the underlying MCL.

During the active inflammatory phase: When the lesion is actively forming — typically 2–10 weeks after the original injury — high-velocity valgus loading techniques at the medial knee should be deferred. The underlying MCL may still carry residual structural compromise, and the calcific mass itself can be acutely tender. The goal during this phase is protection, range-of-motion maintenance, and inflammation control.

In the mature, stable lesion: Once the calcification has matured — typically after 3–6 months — and surrounding soft tissue edema has resolved, a mature PS lesion with intact MCL structure is generally compatible with standard chiropractic care, including lower-extremity manipulation and soft tissue techniques.

How a DACBR report helps: One of the most clinically valuable elements of a dedicated chiropractic radiology report is the explicit statement regarding contraindications to manipulation. A standard radiologist's report will describe the calcification but will not address whether manipulation is appropriate. A DACBR report is written with the chiropractor's treatment decisions in mind — including direct commentary on technique suitability, valgus stress tolerance, and any red flags that would warrant deferral of care.

The symptomatic phase of Pellegrini-Stieda syndrome typically lasts 5–6 months from the onset of calcification. The active inflammatory period — when the calcification is forming and surrounding soft tissue is responding — is the most symptomatic window, usually spanning the first 2–4 months.

However, "going away on its own" requires some nuance:

• Symptoms typically resolve with appropriate conservative management in the majority of young, healthy patients — including activity modification, anti-inflammatory medications, and progressive range-of-motion rehabilitation.
• The calcification itself may or may not resorb. In some cases the ossific mass stabilizes and remains visible on X-ray indefinitely as an asymptomatic mature lesion. In other cases, the calcification does resorb over months to years.
• Without structured rehabilitation, the risk of developing progressive range-of-motion restriction — particularly a flexion contracture — increases. Maintaining knee flexion through the active phase is a clinical priority.

Cases that do not respond to conservative care after 8–12 weeks are appropriate candidates for ultrasound-guided injection — either periligamentous corticosteroid or calcium barbotage, depending on the lesion characteristics. Surgical excision is reserved for a small minority of severely refractory cases and carries a meaningful recurrence rate. The prognosis for young athletes is generally favorable, with full return to sport expected in the majority of cases.

Each modality serves a distinct and complementary purpose. The question is not which is best in isolation, but which is most appropriate at each stage of the clinical workup.

X-ray: the first-line diagnostic tool. Plain radiographs are the standard entry point and are often diagnostic when the lesion is mature (3+ weeks post-injury). The AP view identifies the characteristic curvilinear calcification adjacent to the medial condyle. X-ray is fast, inexpensive, and widely available. Limitation: early calcifications within the first 2–3 weeks may not yet be visible.

Diagnostic ultrasound: the dynamic and procedural modality. Ultrasound provides real-time dynamic assessment of MCL integrity under valgus stress — critical for determining whether residual laxity is present and informing manipulation decisions. It is also the imaging modality of choice for guiding injection or barbotage procedures with precise needle placement. Power Doppler shows inflammatory activity around the lesion and helps time injection appropriately.

MRI: the exclusion and complication modality. MRI is not the first-line study for PS lesion but becomes the most important study when there is clinical suspicion of concurrent pathology. Medial meniscus tears, chondral injury, and partial or full MCL tears can all coexist with PS lesion and are invisible on plain X-ray.

The practical algorithm: start with X-ray to confirm the calcification. Add ultrasound if you are planning injection or want dynamic MCL assessment. Order MRI when there is joint effusion, suspicion of meniscal pathology, or unexplained pain distribution.

Pellegrini-Stieda syndrome is frequently misidentified. The following differentials are the ones most commonly encountered in clinical practice:

• Medial meniscus tear: The most important differential. Medial meniscus tears produce medial joint line pain, possible effusion, and positive McMurray or Thessaly signs — a presentation that closely overlaps with PS syndrome. Critically, MCL and medial meniscus pathology can coexist, so a confirmed PS lesion on X-ray does not exclude a concurrent meniscal tear. MRI is the definitive study when there is any clinical suspicion of meniscal involvement.
• Pes anserine bursitis: Produces medial knee pain distal to the joint line, at the anterior medial tibia. The location is lower and more anterior than the medial femoral condyle. Ultrasound differentiates the two by identifying the bursal fluid collection versus periligamentous calcification.
• Medial compartment osteoarthritis: X-ray will show medial joint space narrowing, subchondral sclerosis, and osteophyte formation — features absent in isolated PS lesion. PS lesion and medial compartment arthritis can coexist.
• Myositis ossificans: Occurs within muscle rather than a ligament. The radiographic zone phenomenon — peripheral dense ossification with central radiolucency — distinguishes it from PS lesion's more uniformly dense calcification.
• Semimembranosus or semitendinosus tendinopathy: Posteromedial knee pain from hamstring tendon insertional pathology. Ultrasound readily distinguishes tendon pathology from periligamentous calcification by identifying the specific structure involved.

When medial knee pain does not fully correlate with the identified imaging finding, further imaging is warranted. A DACBR second-opinion report is specifically designed to identify this kind of disconnect and direct the diagnostic workup appropriately.

The vast majority of patients do not require specialist referral and can be successfully managed within a chiropractic or primary care setting. Specialist referral becomes appropriate under specific circumstances:

• Confirmed MCL grade III tear with significant valgus instability not improving with conservative management
• Concurrent medial meniscus tear confirmed on MRI requiring orthopedic evaluation
• Failure to respond to 8–12 weeks of structured conservative management and at least one image-guided injection
• Significant progressive flexion contracture limiting function
• Imaging findings suggesting an alternative diagnosis requiring further workup

What surgical management involves: For the small minority of refractory cases, surgical excision of the calcific mass is the standard intervention. Several important caveats apply:

• Recurrence rate is significant — PS syndrome has a known tendency to recur after surgical excision, particularly if the underlying soft tissue biology is not addressed and rehabilitation is incomplete.
• MCL compromise risk — when the calcification is large or tightly adherent to the ligament fibers, excision can disrupt MCL structural integrity, potentially necessitating ligament repair in the same operative setting.
• Recovery timeline — post-surgical rehabilitation follows an MCL protocol, with return to sport typically delayed 3–6 months depending on the extent of ligament involvement.

Given these considerations, surgery is appropriately a last resort. The goal is always to exhaust conservative measures — structured rehabilitation, activity modification, and image-guided injection — before escalating to an operative pathway. For a 27-year-old otherwise healthy athlete, this conservative-first approach is strongly preferred by the evidence base.